Graphenano MedicalCare
focuses on the research and development of new graphene derivatives for applications in biomedicine and cosmetics.
Their strategy is based on finding innovative solutions in fields such as the regulation of subcutaneous fat accumulation, skin issues, and applications for dialysis.
In biomedicine, they aim to use graphene as a fat/toxin absorbent and as a skin and muscle regenerator. Additionally, they plan to synthesize new graphene derivatives through various techniques, with an emphasis on safety and the protection of scientific outcomes. Their main goal is to create products that offer added value to the customer.
Graphene, an extraordinarily versatile and resilient material, has emerged as a prominent player in the revolution of medicine and biomedicine. This two-dimensional carbon material, with unique properties, is proving to be an invaluable tool in the quest for innovative solutions to improve human health and reduce associated costs.
Research Lines:
· Hepatic and renal dialysis membranes
· Regeneration of neuronal cells (retinal, macular, and nerve cells)
·Sutures for surgeries.
·Patches for diabetic ulcers and severe burns
·Healing gel
·Pregnancy tests
·Glucose tests
At Graphenano MedicalCare, Graphene in Medicine and Biomedicine: A Revolution in Progress.
The applicability of graphene in medicine goes beyond mere disease detection. Its potential for more efficient therapeutic treatment administration is actively being researched. Graphene nanomaterials can function as drug delivery vehicles, transporting medications directly to affected cells, which not only enhances treatment effectiveness but also reduces side effects.
Graphene Biosensors represent a crucial innovation in the field of diagnostic medicine. These devices, thanks to graphene’s ability to interact with biological molecules, allow for the early detection of diseases with unprecedented precision. This not only accelerates diagnosis but also enables more effective treatments in the early stages of diseases, significantly improving patient outcomes.